Hi, what are you looking for?
– Demand from US institutions has been low at the offering price that Adama seeks. – Please help us out : Will you offer...
/By Kobi Yeshayahou and Hedy Cohen/ The Tamar partners are set to invest $1.5-2 billion in expanding production capacity of the offshore natural...
– The US media giant expects to generate $100 million by using the Israeli content recommendation company’s solutions. – Idan Rabi Israeli content...
– The Soros fund’s portfolio also includes Israeli companies BioBlast Pharma, ClickSoftware Technologies, Kite Pharma, and Mazor Robotics. – Soros Fund Management, George Soros’s...
– The Opko Health Chairman hopes to attain a value of over $100 million for the Rehovot-based vaccination developer. Vaccination company SciGen, controlled...
– The talks involve the sale of 79 BCM of natural gas over 15 years from Egypt’s Damietta installation. – The Tamar natural...
– The company has raised the prices for elemental bromine and hydrobromic acid that it sells in the Far East by 20%. Israel Chemicals...
– Eduardo Elzstain and Moti Ben-Moshe face opposition by Discount Investment bondholders to IDB’s $53 million dividend. – Following opposition by the company’s trustees,...
– Israeli companies raised $3.6 billion in 26 offerings. 2014 was not the best year ever in sales of Israeli companies to foreign...
FIMI Opportunity Funds, controlled by Ishay Davidi, is considering a structural change in Ormat. The proposed change consists of a merger between Ormat...